Moderna Inc. share price logo

Moderna Inc.

NASDAQ: MRNA

Large Cap

$67.27

+7.52

(+12.59%)

as on

Moderna Inc. Stock Performance

as on June 27, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $59.33
    $69.28
    downward going graph

    11.80%

    Downside

    2.99%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $22.28
    $67.74
    downward going graph

    66.88%

    Downside

    0.70%

    Upside

    downward going graph

Moderna Inc. share price movements today

Previous Close
$59.75
Open
$59.43
Volume
12.3M
Day's Low - High
$59.33 - $69.28
52 Week Low - High
$22.28 - $67.74

Moderna Inc. Historical Returns

1 Month Return
+ 27.05 %
3 Month Return
+ 11.54 %
1 Year Return
+ 116.96 %
3 Year Return
-50.38 %
5 Year Return
-72.83 %

Moderna Inc. Stock Fundamentals & Key Indicators

Check Moderna Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$24.0B

EPS (TTM)

-8.6454

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.85%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-2.3B

Revenue (TTM)

2.2B

Profit Margin

-143.55%

Return On Equity TTM

-36.56%

Moderna Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Moderna Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Moderna Inc. image
Moderna Inc.
BUY$24.0B-72.83%NA-143.55%NA
Alnylam Pharmaceuticals Inc. image
Alnylam Pharmaceuticals Inc.
BUY$39.3B67.15%74.0712.55%NA
Vertex Pharmaceuticals Inc. image
Vertex Pharmaceuticals Inc.
BUY$120.6B147.08%28.1735.51%NA
Regeneron Pharmaceuticals Inc. image
Regeneron Pharmaceuticals Inc.
BUY$65.4B12.64%15.2229.65%0.58%

Stock Returns calculator for Moderna Inc. Stock including INR - Dollar returns

The Moderna Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Moderna Inc. investment value today

Current value as on today

₹2,68,775

Returns

₹1,68,775

(+168.77%)

Returns from Moderna Inc. Stock

₹1,44,263 (+144.26%)

Dollar Impact

₹24,512 (+24.51%)

Analyst Recommendation on Moderna Inc. Stock

Based on 31 analysts

BUY

54.84%

Buy

35.48%

Hold

9.68%

Sell

Based on 31 analysts, 54.84% of analysts recommend a 'BUY' rating for Moderna Inc.. Average target price of $43.45

Moderna Inc. Share Price Target

Get share price movements and forecasts by analysts on Moderna Inc..

What analysts predicted

-54.82%DOWNSIDE

Target Price

$43.45

Current Price

$67.27

Analyzed by

31 Analysts

Target

$43.45

Moderna Inc. target price $43.45, a slight downside of -54.82% compared to current price of $67.27. According to 31 analysts rating.

Indian Investors' Interest in Moderna Inc. Stock

Investment in Moderna Inc. Shares on INDmoney has dropped by -2.98% in the last 30 days, indicating reduced investment activity.

Time period: to

Change:-2.98% versus previous 30 day period

Search interest for Moderna Inc. Stock has decreased by -10% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-10% versus previous 30 day period

Moderna Inc. Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
2,813
167
221
1,855
956
107
142
1,016
678
389
Gross Profit
1,884
71
106
1,341
217
17
23
8
226
-566
Operating Income
6
-1,266
-1,363
-70
-1,246
-1,050
-907
-260
-857
-1,388
EBITDA
278
-1,123
-1,232
79
-1,118
-924
-760
-135
-732
-1,258
Interest Expense
6
6
6
6
6
1
1
-
8
17
Depreciation
202
36
41
52
60
39
57
52
67
59
Income Before Tax
70
-1,165
-1,279
21
-1,184
-964
-818
-187
-799
-1,334
Income Tax Expense
-147
10
-
8
-64
7
7
13
27
9
Net Income
217
-1,175
-1,279
13
-1,120
-971
-825
-200
-826
-1,343
Net Profit Margin
7.71%
-703.59%
-578.73%
0.70%
-117.15%
-907.48%
-580.99%
-19.69%
-121.83%
-345.24%

Moderna Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
108
205
122
48
274
17,736
18,875
6,848
3,199
1,944
Gross Profit
93
185
-331
48
266
15,119
13,459
2,155
1,735
1,076
Operating Income
-223
-269
-413
-545
-763
13,296
9,420
-4,239
-3,945
-3,074
EBITDA
-208
-235
-388
-514
-731
13,528
9,952
-3,283
-3,394
-2,553
Interest Expense
-
0
3
6
9
18
29
38
24
10
Depreciation
-
20
24
31
31
232
348
499
189
215
Income Before Tax
-215
-255
-384
-514
-744
13,285
9,575
-3,942
-3,607
-2,768
Income Tax Expense
1
0
0
0
2
1,083
1,213
772
-46
54
Net Income
-216
-255
-384
-514
-747
12,202
8,362
-4,714
-3,561
-2,822
Net Profit Margin
-199.46%
-124.34%
-314.04%
-1070.07%
-272.16%
68.80%
44.30%
-68.84%
-111.32%
-145.16%

Moderna Inc. Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-1,175
-1,279
13
-1,120
-971
-825
-200
-826
-1,343
Operating Cash Flow
-989
-1,274
-1,566
825
-1,037
-919
-847
951
-630
Investing Cash Flow
118
1,649
721
-539
730
564
700
-48
-76
Financing Cash Flow
14
34
11
-3
4
9
-1
560
17
Change in Cash
-857
409
-833
282
-303
-345
-147
1,462
-688

Moderna Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-255
-384
-514
-747
12,202
8,362
-4,714
-3,561
-2,822
Operating Cash Flow
-331
-330
-458
2,026
13,620
4,981
-3,118
-3,004
-1,873
Investing Cash Flow
416
-372
-14
-1,671
-8,523
-5,176
4,206
1,949
1,946
Financing Cash Flow
0
1,226
51
2,033
-873
-3,448
-1,377
56
593
Change in Cash
84
523
-422
2,388
4,224
-3,643
-289
-999
668

Mutual Funds that own Moderna Inc. Stock

Check out the Mutual Funds with significant holdings in Moderna Inc..

Funds
Holdings
Shares Held
Motilal Oswal S&P 500 Index Fund Direct Growth
Motilal Oswal S&P 500 Index Fund Direct Growth
0.02501%
2555

Global Institutional Holdings in Moderna Inc.

Funds
Holdings
The Goldman Sachs Group Inc
1.66%
Amvescap Plc.
1.21%
BNP Paribas Arbitrage, SA
1.09%
Alyeska Investment Group, L.P.
1.02%
FMR Inc
11.51%
See all

Moderna Inc. News & Key Events

  • img

    Today's Timeline - 26 June

    Fri, 04:30 PM

    -

    Moderna announced expanded collaboration with CEPI for developing a vaccine against Bundibugyo ebolavirus.

    Fri, 09:31 PM

    -

    Moderna shares surged 14% after FDA endorsed flu vaccine and reported Q1 revenue beating expectations.

    Fri, 10:29 PM

    -

    Moderna shares jumped 11% after detailing long-term strategy at Science Day, focusing on oncology and rare disease treatments.

Insights on Moderna Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, MRNA has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, MRNA stock has moved up by 41.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has experienced a drawdown of -45.3%, however Alnylam Pharmaceuticals, Inc. Common Stock resisted the overall trend and outperformed by 35.7%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 3 quarters, 1.01B → 389.0M (in $), with an average decrease of 38.0% per quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, -200.0M → -1.34B (in $), with an average decrease of 187.8% per quarter

About Moderna Inc.

Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company's respiratory vaccines include spikevax, mNEXSPIKE, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, and human immunodeficiency virus vaccines; enteric viruses include norovirus; public health vaccines consist of Zika, Nipah, and Mpox vaccines; and bacterial diseases vaccines, such as lyme vaccines. It also provides oncology therapeutics, such as intismeran autogene, cancer antigen therapy, t-cell engager, and cell therapy enhancer; and rare disease products, including propionic and methylmalonic acidemia, and cystic fibrosis. It has strategic alliances and collaborations with Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; immatics N.V.; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; The Bill & Melinda Gates Foundation; and OpenAI. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
OrganisationModerna Inc.
Headquarters325 Binney Street, Cambridge, MA, United States, 02142
IndustryBiotechnology
CEOMr. Stéphane Bancel M.B.A.
E-voting on sharesClick here to vote

Key Management of Moderna Inc.

Name

Title

Mr. Stéphane Bancel M.B.A.

CEO & Director

Ms. Shannon Thyme Klinger J.D.

Chief Legal Officer & Corporate Secretary

Dr. Jerh Collins Ph.D.

Chief Technical Operations & Quality Officer

Dr. Stephen Hoge M.D.

President

Mr. James M. Mock

Chief Financial Officer

Ms. Lavina Talukdar CFA

Senior VP & Head of Investor Relations

Ms. Tracey Franklin

Chief People & Digital Technology Officer

Dr. Charbel Haber M.P.H., Ph.D.

Senior VP & Head of Global Regulatory Science

Mr. Patrick Norman Bergstedt

Senior Vice President of Commercial Vaccines

Dr. John Lepore J.D., M.D.

Senior Vice President of Government Engagement

FAQs

What is Moderna Inc. share price today?

Moderna Inc. share price today is $67.27 as on at the close of the market. Moderna Inc. share today touched a day high of $69.28 and a low of $59.33.

What is the 52 week high and 52 week low for Moderna Inc. share?

Moderna Inc. share touched a 52 week high of $67.74 on and a 52 week low of $22.28 on . Moderna Inc. stock price today i.e. is closed at $67.27,which is 0.69% down from its 52 week high and 201.93% up from its 52 week low.

What is Moderna Inc.'s market capitalisation today?

Moderna Inc. market capitalisation is $0.02T as on .

How to invest in Moderna Inc. Stock (MRNA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Moderna Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Moderna Inc. Shares that will get you 0.0223 shares as per Moderna Inc. share price of $67.27 per share as on June 27, 2026 at 8:46 am IST.

What is the minimum amount required to buy Moderna Inc. Stock (MRNA) from India?

Indian investors can start investing in Moderna Inc. (MRNA) shares with as little as ₹94.3 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹943.00 in Moderna Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Moderna Inc. share’s latest price of $67.27 as on June 27, 2026 at 8:46 am IST, you will get 0.1487 shares of Moderna Inc.. Learn more about fractional shares .

What are the returns that Moderna Inc. has given to Indian investors in the last 5 years?

Moderna Inc. stock has given -72.83% share price returns and 27.1% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?